MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

18 May 2023 Evaluate
The sales surged to Rs. 25793.00 millions, up 30.48% for the March 2023 quarter as against Rs. 19768.00 millions during the corresponding quarter previous year.Profit for the quarter ended March 2023 rises by 98.74% to Rs. 4907.00  millions from Rs. 2469.00 millions.Operating Profit saw a handsome growth to 10237.00 millions from 5113.00 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 25793.00 19768.00 30.48 87316.00 78369.00 11.42 87316.00 78369.00 11.42
Other Income 2512.00 537.00 367.78 5484.00 1787.00 206.88 5484.00 1787.00 206.88
PBIDT 10237.00 5113.00 100.22 30028.00 20968.00 43.21 30028.00 20968.00 43.21
Interest 850.00 420.00 102.38 2782.00 1349.00 106.23 2782.00 1349.00 106.23
PBDT 7349.00 4693.00 56.59 25208.00 16426.00 53.46 25208.00 16426.00 53.46
Depreciation 1199.00 1228.00 -2.36 4886.00 4787.00 2.07 4886.00 4787.00 2.07
PBT 6150.00 3465.00 77.49 20322.00 11639.00 74.60 20322.00 11639.00 74.60
TAX 1243.00 996.00 24.80 5030.00 3060.00 64.38 5030.00 3060.00 64.38
Deferred Tax -53.00 217.00 -124.42 412.00 458.00 -10.04 412.00 458.00 -10.04
PAT 4907.00 2469.00 98.74 15292.00 8579.00 78.25 15292.00 8579.00 78.25
Equity 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17
PBIDTM(%) 39.69 25.87 53.45 34.39 26.76 28.53 34.39 26.76 28.53
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..